Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of Oxybutynin
Open Access
- 8 September 2016
- journal article
- research article
- Published by Springer Nature in The AAPS Journal
- Vol. 18 (6) , 1532-1549
Abstract
A new minimal Segmented Transit and Absorption model (mSAT) model has been recently proposed and combined with intrinsic intestinal effective permeabilityKeywords
Funding Information
- University of Manchester
This publication has 90 references indexed in Scilit:
- Combining the ‘bottom up’ and ‘top down’ approaches in pharmacokinetic modelling: fittingPBPKmodels to observed clinical dataBritish Journal of Clinical Pharmacology, 2014
- Minimal output sets for identifiabilityMathematical Biosciences, 2012
- A mechanism-Based Approach for Absorption Modeling: The Gastro-Intestinal Transit Time (GITT) ModelThe AAPS Journal, 2012
- Population-Based Mechanistic Prediction of Oral Drug AbsorptionThe AAPS Journal, 2009
- Toward an Increased Understanding of the Barriers to Colonic Drug Absorption in Humans: Implications for Early Controlled Release Candidate AssessmentMolecular Pharmaceutics, 2009
- Carboxylesterase in the liver and small intestine of experimental animals and humanLife Sciences, 2007
- Different segmental transit times in patients with irritable bowel syndrome and “normal” colonic transit time: is there a correlation with symptoms?Techniques in Coloproctology, 2006
- THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”Drug Metabolism and Disposition, 2006
- Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and OxybutyninClinical Pharmacokinetics, 2004
- Simultaneous measurement of gastric emptying, small bowel residence and colonic filling of a solid meal by the use of the gamma camera.Gut, 1986